Displaying 13 - 22 of 22
Metabolism, Alcohol & Toxicity

Session 1: Identifying Patients with NASH and Significant Fibrosis: Are we doing enough?

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 2: Managing patients with NASH and Significant Fibrosis – Now and in the future

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 3: Treating patients with NASH and Significant Fibrosis, what the future holds?

Webcasts
View
Metabolism, Alcohol & Toxicity

Discussion

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Welcome and introduction

Webcasts
View
Immune-Mediated and Cholestatic Diseases

PFIC in practice: Paediatric and adult case studies of patients with idiopathic cholestasis

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity
Live discussion

Live discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH

The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Challenges in the Management of Patients with Cholestatic Liver Diseases

Webcasts
View